MedPharm’s CSO Co-authors New Book on Formulation Development
MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
The Art and Science of Dermal Formulation development provides a comprehensive guide to all aspects of the subject, from the structure of skin and formulation development and performance testing to the chemical, physical and technological modulation of delivery and manufacturing processes.
Professor Brown said: “The book covers early stage preformulation and formulation development right through to product manufacture. Much of the information is based on the systems, processes and expertise we have built up at MedPharm over the years and which have successfully led to the commercial launch of over 50 products by our clients.
Prof. Brown continued: “The demand within the pharmaceutical industry for these specialised and complex development services continues to grow as more becomes known about the important biochemical process occurring in the skin. This shift within the industry has been reflected in the expanding demand for MedPharm’s services.”
You can read the full story at CPhI online.
For more information on “The Art and Science of Dermal Formulation Development” please visit here.
Notes to editors
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established R&D centres in the USA and UK and has its global HQ in Guildford, UK.